Defective Neuromuscular Transmission in the SOD1G93A Transgenic Mouse Improves After Administration of Human Umbilical Cord Blood Cells

Stem Cell Reviews and Reports

Volumn 8, Issue 1, 2012, Pages 224-228

  Souayah, Nizar ^a,b   Coakley, K M ^a   Chen, R ^a   Ende, Norman ^a   McArdle, Joseph J ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b NONE   (United States)

Author keywords

Amyotrophic lateral sclerosis; Human umbilical cord blood; Neuromuscular transmission; Transplantation

Indexed keywords

MUS; MUS MUSCULUS;

EID: 84857654420     PISSN: 15508943     EISSN: 15586804     Source Type: Journal    
DOI: 10.1007/s12015-011-9281-3     Document Type: Article

References (36)

1. Rowland, L. P., & Shneider, N. A. (2001). Amyotrophic lateral sclerosis. The New England Journal of Medicine, 344, 1688-1700.
2. Cleveland, D. W., & Rothstein, J. D. (2001). From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nature Reviews, 2, 806-819.
3. Gurney, M. E. (1994). Transgenic-mouse model of amyotrophic lateral sclerosis. The New England Journal of Medicine, 331, 1721-1722.
4. Gurney, M. E., Pu, H., Chiu, A. Y., et al. (1994). Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science, 264, 1772-1775.
5. Rosen, D. R., Sapp, P., O'Regan, J., et al. (1994). Genetic linkage analysis of familial amyotrophic lateral sclerosis using human chromosome 21 microsatellite DNA markers. American Journal of Medical Genetics, 51, 61-69.
6. Rosen, D. R., Siddique, T., Patterson, D., et al. (1993). Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature, 362, 59-62.
7. Kim, H. J., Lee, J. H., & Kim, S. H. (2009). Therapeutic effects of human mesenchymal stem cells for traumatic brain injury in rats: secretion of neurotrophic factors and inhibition of apoptosis. Journal of Neurotrauma, 27, 131-8.
8. Snyder, E. Y. (2006). Special issue: the intersection of stem/progenitor cell biology and hypoxic-ischemic cerebral injury/stroke. Experimental Neurology, 199, 1-4.
9. Mitsui, T., Shumsky, J. S., Lepore, A. C., Murray, M., & Fischer, I. (2005). Transplantation of neuronal and glial restricted precursors into contused spinal cord improves bladder and motor functions, decreases thermal hypersensitivity, and modifies intraspinal circuitry. Journal of Neuroscience, 25, 9624-9636.
10. Wu, W., Chen, X., Hu, C., Li, J., Yu, Z., & Cai, W. (2010). Transplantation of neural stem cells expressing hypoxia-inducible factor-1alpha (HIF-1alpha) improves behavioral recovery in a rat stroke model. Journal of Clinical Neuroscience, 17, 92-5.
11. Bicknese, A. R., Goodwin, H. S., Quinn, C. O., Henderson, V. C., Chien, S. N., & Wall, D. A. (2002). Human umbilical cord blood cells can be induced to express markers for neurons and glia. Cell Transplantation, 11, 261-264.
12. Chen, N., Hudson, J. E., Walczak, P., et al. (2005). Human umbilical cord blood progenitors: the potential of these hematopoietic cells to become neural. Stem Cells, 23, 1560-1570.
13. Chen, R., & Ende, N. (2000). The potential for the use of mononuclear cells from human umbilical cord blood in the treatment of amyotrophic lateral sclerosis in SOD1 mice. Journal of Medicine, 31, 21-30.
14. Ende, N., Weinstein, F., Chen, R., & Ende, M. (2000). Human umbilical cord blood effect on sod mice (amyotrophic lateral sclerosis). Life Sciences, 67, 53-59.
15. Nicaise, C., Mitrecic, D., Demetter, P., et al. (2009). Impaired blood-brain and blood-spinal cord barriers in mutant SOD1-linked ALS rat. Brain Research, 1301, 152-162.
16. Rizvanov, A. A., Kiyasov, A. P., Gaziziov, I. M., et al. (2008). Human umbilical cord blood cells transfected with VEGF and L(1)CAM do not differentiate into neurons but transform into vascular endothelial cells and secrete neuro-trophic factors to support neuro-genesis-a novel approach in stem cell therapy. Neurochemistry International, 53, 389-394.
17. Garbuzova-Davis, S., Sanberg, C. D., Kuzmin-Nichols, N., et al. (2008). Human umbilical cord blood treatment in a mouse model of ALS: optimization of cell dose. PloS One, 3, e2494.
18. Garbuzova-Davis, S., Saporta, S., Haller, E., et al. (2007). Evidence of compromised blood-spinal cord barrier in early and late symptomatic SOD1 mice modeling ALS. PloS One, 2, e1205.
19. Garbuzova-Davis, S., Willing, A. E., Zigova, T., et al. (2003). Intravenous administration of human umbilical cord blood cells in a mouse model of amyotrophic lateral sclerosis: distribution, migration, and differentiation. Journal of Hematotherapy & Stem Cell Research, 12, 255-270.
20. Habisch, H. J., Janowski, M., Binder, D., et al. (2007). Intrathecal application of neuroectodermally converted stem cells into a mouse model of ALS: limited intraparenchymal migration and survival narrows therapeutic effects. Journal of Neural Transmission, 114, 1395-1406.
21. McArdle, J. J. (1975). Complex endplate potentials at the regenerating neuromuscular junction of the rat. Experimental Neurology, 49, 629-638.
22. Ferrucci, M., Spalloni, A., Bartalucci, A., et al. (2010). A systematic study of brainstem motor nuclei in a mouse model of ALS, the effects of lithium. Neurobiology of Disease, 37, 370-383.
23. Suchy, J., Lee, S., Ahmed, A., & Shea, T. B. (2010). Dietary supplementation with S-adenosyl methionine delays the onset of motor neuron pathology in a murine model of amyotrophic lateral sclerosis. Neuromolecular Medicine, 12, 86-97.
24. Martinez, J. A., Francis, G. J., Liu, W. Q., et al. (2008). Intranasal delivery of insulin and a nitric oxide synthase inhibitor in an experimental model of amyotrophic lateral sclerosis. Neuroscience, 157, 908-925.
25. Wong, M., & Martin, L. J. (2010). Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic mice. Human Molecular Genetics, 19, 2284-2302.
26. Fischer, L. R., Culver, D. G., Tennant, P., et al. (2004). Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Experimental Neurology, 185, 232-240.
27. Shefner, J. M., Reaume, A. G., Flood, D. G., et al. (1999). Mice lacking cytosolic copper/zinc superoxide dismutase display a distinctive motor axonopathy. Neurology, 53, 1239-1246.
28. Zhou, C., Zhao, C. P., Zhang, C., Wu, G. Y., & Xiong, F. (2007). A method comparison in monitoring disease progression of G93A mouse model of ALS. Amyotrophic Lateral Sclerosis, 8, 366-372.
29. Shefner, J. M., Cudkowicz, M., & Brown, R. H., Jr. (2006). Motor unit number estimation predicts disease onset and survival in a transgenic mouse model of amyotrophic lateral sclerosis. Muscle & Nerve, 34, 603-607.
30. Shefner, J. M., Brown, R. H., Jr., Cole, D., et al. (2001). Effect of neurophilin ligands on motor units in mice with SOD1 ALS mutations. Neurology, 57, 1857-1861.
31. Borlongan, C. V., Hadman, M., Sanberg, C. D., & Sanberg, P. R. (2004). Central nervous system entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke. Stroke, 35, 2385-2389.
32. Xiao, J., Nan, Z., Motooka, Y., & Low, W. C. (2005). Transplantation of a novel cell line population of umbilical cord blood stem cells ameliorates neurological deficits associated with ischemic brain injury. Stem Cells and Development, 14, 722-733.
33. Bachstetter, A. D., Pabon, M. M., Cole, M. J., et al. (2008). Peripheral injection of human umbilical cord blood stimulates neurogenesis in the aged rat brain. BMC Neuroscience, 9, 22.
34. Rameshwar, P., Smith, I., Ende, N., Batarseh, H. E., & Ponzio, N. M. (1999). Endogenous hematopoietic reconstitution induced by human umbilical cord blood cells in immunocompromised mice: implications for adoptive therapy. Experimental Hematology, 27, 176-185.
35. Gyorffy, C., & Nicolucci, J. (2009). What are the common causes of facial neuropathy? Journal of the Canadian Dental Association, 75, 103-104.
36. Garbuzova-Davis, S., Saporta, S., & Sanberg, P. R. (2008). Implications of blood-brain barrier disruption in ALS. Amyotrophic Lateral Sclerosis, 9, 375-376.